Latest News & Updates of Loncom Pharma

Darolutamide: A Promising Advancement in Prostate Cancer TreatmentDarolutamide, a next-generation androgen receptor inhibitor, has emerged as a promising therapeutic option for patients with prostate cancer, particularly those with non-metastatic castration-resistant prostate cancer (nmCRPC). This m

lagolix sodium, a novel oral medication, represents a significant advancement in the treatment of endometriosis and uterine fibroids, conditions that affect millions of women worldwide. Endometriosis, characterized by the growth of endometrial-like tissue outside the uterus, causes severe pain and i

ShandongLoncom Co., Ltd. is proud to announce that our four products obtained WC certification. The four certified products include Silodosin,Elagolix sodium,Daprodustat and Vonprazon Fumarate.

In the ever-evolving landscape of pharmaceutical advancements, Ilaprazole has emerged as a promising new treatment for gastroesophageal conditions, offering potential relief for millions of patients worldwide. As an innovative proton pump inhibitor (PPI), Ilaprazole is set to challenge the establish